HaploSeq: New Approach Determines Whether Your DNA from Mother or Father

Researchers have developed a new technique that is able to determine whether a particular genetic sequence comes from an individual’s mother or father. The technique, named HaploSeq, promises to accelerate studies of how genes contribute to disease, improve the process of matching donors with organs and help scientists better understand human migration patterns.

DNA. Image credit: Richard Wheele / CC BY-SA 3.0.

“The technique will enable clinicians to better assess a person’s individual risk for disease. It is potentially transformative for personalized medicine,” explained Dr Bing Ren from the University of California, who is a senior author of an article in the journal Nature Biotechnology.

“Current sequencing technologies are fast and rapidly getting cheaper – an individual’s genome can now be sequenced in about a week for USD 5,000. In the not too distant future, everyone’s genome will be sequenced. That will become the standard of care. There has been a problem with this scenario.”

Except for the sex chromosomes, everyone has two copies of each chromosome. One copy comes from mom, and the other from dad. Current techniques cannot distinguish between the two copies of each gene and, therefore, are not very good at determining whether particular genetic differences, such as a single-letter change in the DNA, originate with an individual’s mother or father – muddying genetic analyses.

HaploSeq – a mixture of molecular biology and computational biology approaches – bypasses this problem. The method enables researchers to quickly determine which genetic variants occur together on the same stretch of chromosome and, therefore, came from the same parent.

“This advance has direct implications for the utility of genomics in clinical practice and will also have profound effects on genetic research and discovery,” said lead author Dr Siddarth Selvaraj from the University of California.

More immediately, HaploSeq will enable clinicians to better assess a person’s individual risk for disease, a cornerstone of personalized medicine. For instance, people at risk for a disease such as cancer often have more than one DNA mutation.

HaploSeq could enable clinicians to determine if the two mutations are on the same chromosome or on different chromosomes, which can help in risk assessment – for instance, risk may be reduced if two mutations are on the same chromosome, since the ‘good’ chromosome can often compensate.

Similarly, the method, with further honing, has the potential to refine the currently cumbersome process of determining whether there is a genetic match between an organ donor and recipient. A large number of genes contribute to compatibility between donor and recipient, but there is a lot of genetic variability in these genes.

The new technique could help determine whether DNA differences between donor and recipient are likely to be a good match. It will also help researchers analyze human migration and determine ancestry from their DNA sequences.